The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify.

Melissa Hortman was the Minnesota House's top Democrat and as House speaker helped shepherd a package of liberal initiatives ...